Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Santa Rosa, CA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Torrance, CA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Whittier, CA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Denver, CO
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Golden, CO
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Golden, CO
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Littleton, CO
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Littleton, CO
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Norwich, CT
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Norwich, CT
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Stamford, CT
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Stamford, CT
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Daytona Beach, FL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Daytona Beach, FL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Lakeland, FL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Lakeland, FL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
New Port Richey, FL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Plantation, FL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Plantation, FL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Stuart, FL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Stuart, FL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Augusta, GA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Thomasville, GA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Thomasville, GA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Elmhurst, IL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Elmhurst, IL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Gurnee, IL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Gurnee, IL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Mount Vernon, IL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Mount Vernon, IL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Skokie, IL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Skokie, IL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Urbana, IL
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Urbana, IL
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Indianapolis, IN
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
South Bend, IN
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
South Bend, IN
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Sioux City, IA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Sioux City, IA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Waterloo, IA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Waterloo, IA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Hutchinson, KA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Hutchinson, KA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Lexington, KY
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Louisville, KY
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Paducah, KY
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Paducah, KY
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Alexandria, LA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Alexandria, LA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Lafayette, LA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Lafayette, LA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Marrero, LA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Marrero, LA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Shreveport, LA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Cumberland, MD
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Cumberland, MD
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Randallstown, MD
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Randallstown, MD
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Rockville, MD
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Westminster, MD
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Westminster, MD
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Lowell, MA
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Lowell, MA
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Battle Creek, MI
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Battle Creek, MI
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Duluth, MN
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Duluth, MN
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Jackson, MS
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Jefferson City, MO
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Jefferson City, MO
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Kansas City, MO
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Saint Joseph, MO
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Billings, MT
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Omaha, NE
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Nashua, NH
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Nashua, NH
Click here to add this to my saved trials
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  1/5/2018
Clinical Research Facility
mi
from
Denville, NJ
NOLAN: Naproxen or Loratadine and Neulasta
Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 1/5/2018
Clinical Research Facility
mi
from
Denville, NJ
Click here to add this to my saved trials